Nanomedicines for Infectious Diseases.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Works in Pharmaceutical Research, 2019, Vol 36, Issue 4
Results: 16
1
2
A Comprehensive Physicochemical, In Vitro and Molecular Characterization of Letrozole Incorporated Chitosan-Lipid Nanocomplex.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2597-4
- By:
- Publication type:
- Article
3
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2596-5
- By:
- Publication type:
- Article
4
Biomimetic Hydroxyapatite a Potential Universal Nanocarrier for Cellular Internalization & Drug Delivery.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2594-7
- By:
- Publication type:
- Article
5
Recovery of OATP1B Activity after Living Kidney Transplantation in Patients with End-Stage Renal Disease.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2593-8
- By:
- Publication type:
- Article
6
New Insights into Using Lipid Based Suspensions for 'Brick Dust' Molecules: Case Study of Nilotinib.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2590-y
- By:
- Publication type:
- Article
7
Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2589-4
- By:
- Publication type:
- Article
8
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2588-5
- By:
- Publication type:
- Article
9
Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2577-8
- By:
- Publication type:
- Article
10
A Macromolecular Janus Kinase (JAK) Inhibitor Prodrug Effectively Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2587-6
- By:
- Publication type:
- Article
11
Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
12
Evaluation of the Immunomodulatory Effects of All-Trans Retinoic Acid Solid Lipid Nanoparticles and Human Mesenchymal Stem Cells in an A549 Epithelial Cell Line Model.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2583-x
- By:
- Publication type:
- Article
13
A Multifunctional Hydrogel Delivers Gold Compound and Inhibits Human Lung Cancer Xenograft.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2581-z
- By:
- Publication type:
- Article
14
The Controlled Release and Anti-Inflammatory Activity of a Tetramethylpyrazine-Loaded Thermosensitive Poloxamer Hydrogel.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2580-0
- By:
- Publication type:
- Article
15
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2586-7
- By:
- Publication type:
- Article
16
A Theoretical Model for the Cell Cycle and Drug Induced Cell Cycle Arrest of FUCCI Systems with Cell-to-Cell Variation during Mitosis.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 4, p. N.PAG, doi. 10.1007/s11095-019-2570-2
- By:
- Publication type:
- Article